| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000073440A8 Pollinosis-associated gene 787 |
| 03/15/2001 | WO2000071080A3 Interaction of the cyclic-amp-specific phosphodiesterase pde4d5 with rack1 |
| 03/15/2001 | WO2000068362A3 Undifferentiated erythroid cells and their use in ligand binding assays |
| 03/15/2001 | WO2000066154A3 Anti-microbial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 03/15/2001 | WO2000061800A3 Method for the analysis of aflp® reaction mixtures using primer extension techniques |
| 03/15/2001 | WO2000061798A3 Method for mapping a dna molecule comprising an ad infinitum amplification step |
| 03/15/2001 | WO2000046402A8 Genomic analysis method |
| 03/15/2001 | WO2000033635A3 Primer-independent rna synthesis catalyzed by hcv polymerase |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | DE19943743A1 Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays A process for the identification of binding partners with position-specific arrays |
| 03/15/2001 | DE19936618A1 Diagnostisches Kit und dessen Verwendung The diagnostic kit and its use |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | DE19925073A1 Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung Nucleic acid molecules with specific detection of native PrP c · S · · ·, production and use |
| 03/15/2001 | DE10014639A1 cDNSen mit einer Kodierung von Enzymen zur Fructan-Synthese mit einer Niedertemperatur-Expression sowie Verfahren zu deren Isolierung cDNSen with a coding for enzymes of fructan synthesis with a low-temperature expression as well as methods for their isolation |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2386607A1 Method for identifying binding partners with position-specific arrays |
| 03/15/2001 | CA2384777A1 T2r taste receptor family |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384496A1 Luciferase expression cassettes and methods of use |
| 03/15/2001 | CA2384368A1 Method of detecting of screening cancer or precancer by determining the amount and integrity of nucleic acids |
| 03/15/2001 | CA2384146A1 Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384029A1 Diagnostic and therapeutic methods in autoimmune disease |
| 03/15/2001 | CA2384021A1 Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383885A1 Crystal structure of a deacetylase and inhibitors thereof |
| 03/15/2001 | CA2383857A1 Detection of alterations in a gene by long range pcr using human mobile elements |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383776A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383321A1 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | CA2383186A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | CA2382870A1 A detergent composition containing a protease |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2381987A1 Improved method for nucleotide detection and devices used therein |
| 03/15/2001 | CA2379536A1 Dihydroorotase extracted from plants |
| 03/15/2001 | CA2348657A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/14/2001 | EP1083235A2 Reduced coenzyme solution |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |
| 03/14/2001 | EP1083223A1 Novel immortalized hepatic cell line originating in humans |
| 03/14/2001 | EP1082614A1 Method and device for detecting analytes in fluids |
| 03/14/2001 | EP1082607A1 Surface regeneration of biosensors |
| 03/14/2001 | EP1082466A1 Method, reagent and kit for genotyping of human papillomavirus |
| 03/14/2001 | EP1082465A2 Method for detecting microorganisms in products |
| 03/14/2001 | EP1082464A1 Method for determining antigens |
| 03/14/2001 | EP1082463A1 Mechanical stress induced genes, expression products therefrom, and uses thereof |
| 03/14/2001 | EP1082462A1 Identification of molecular interaction sites in rna for novel drug discovery |
| 03/14/2001 | EP1082461A1 Method for amplifying at least a particular nucleotide sequence and primers used |
| 03/14/2001 | EP1082460A1 A novel method of diagnosing, monitoring, and staging prostate cancer |
| 03/14/2001 | EP1082459A1 A novel method of diagnosing, monitoring, and staging lung cancer |
| 03/14/2001 | EP1082458A1 Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| 03/14/2001 | EP1082457A2 Nucleic acid encoding rate agouti related protein |
| 03/14/2001 | EP1082456A1 Antisense modulation of cd40 expression |
| 03/14/2001 | EP1082455A1 Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams |
| 03/14/2001 | EP1082454A1 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy |
| 03/14/2001 | EP1082453A1 Liquid reagent set for l-lactate determination |
| 03/14/2001 | EP1082452A1 Transition state binding assay |
| 03/14/2001 | EP1082451A2 Method for determining antibiotics with beta-lactam core in a biological fluid |
| 03/14/2001 | EP1082441A1 Mycobacterial n-acetyltransferases |
| 03/14/2001 | EP1082437A1 Xenobiotic related induction of gene expression |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082429A2 TUMOUR SUPPRESSOR GENES OF THE p53 FAMILY |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082424A1 Tumor suppressor |
| 03/14/2001 | EP1082423A1 Cyclin e2 genes and proteins |
| 03/14/2001 | EP1082421A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 03/14/2001 | EP1082416A2 Poly(adp-ribose)polymerase gene |
| 03/14/2001 | EP1082413A2 Aav5 vector and uses thereof |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082336A2 Apoptosis modulators that interact with the huntington's disease gene |
| 03/14/2001 | EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082297A1 Substituted dithio-bis-nitrobenzenes and their applications |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP0975427B1 A device for performing an assay, use of a membrane in the manufacture of said device, kit comprising said device and method for the detection of an analyte using such device. |
| 03/14/2001 | EP0925504B1 Method for detecting and/or quantifying a gliotoxic factor |
| 03/14/2001 | EP0569527B1 Inherited and somatic mutations of apc gene in colorectal cancer of humans |
| 03/14/2001 | CN1287689A Affinity based self-assembly systems and devices for photonic and electronic applications |
| 03/14/2001 | CN1287177A Method of screening genovariant and protein combining DNA segment |
| 03/14/2001 | CN1287176A Method of modifying and cloning nucleic acid target molecule |
| 03/14/2001 | CN1287175A Water culture bacterination process to determine bacterial wilt resistance of plant |
| 03/14/2001 | CN1287173A Human 3-phosphoserine transferase and its code sequence, preparation and application |
| 03/14/2001 | CN1287172A Human uridine kinase and its code sequence, preparation and application |
| 03/14/2001 | CN1287171A Human neuron calcium sensing protein and its code sequence, preparation and use |
| 03/14/2001 | CN1287170A New human nerve mass-transferring protein and its code sequence |
| 03/14/2001 | CN1287169A New human G protein protomer and its code sequence |
| 03/14/2001 | CN1287168A New human hair protein and its sequence |
| 03/14/2001 | CN1063226C Method for detecting & screening bioactivity active constituent additive for cosmetics |
| 03/13/2001 | US6201979 Chemical signal-impermeable mask |
| 03/13/2001 | US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control |
| 03/13/2001 | US6201114 Identification of congenital stationary night blindness in dogs |
| 03/13/2001 | US6201113 Dna of a primer and a dnazyme-encoding zymogene; detection and quantitation of target nucleic acid sequence in a sample |
| 03/13/2001 | US6201112 Method for 3′ end-labeling ribonucleic acids |